243 related articles for article (PubMed ID: 16996571)
21. Pathogenicity of A600V variant in exon 12 of the MSH2 gene detected in a Japanese kindred with Lynch syndrome.
Miyakura Y; Sugano K; Nomizu T; Lefor A; Yasuda Y
Jpn J Clin Oncol; 2012 Jan; 42(1):78-82. PubMed ID: 22086974
[TBL] [Abstract][Full Text] [Related]
22. A 10-Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred.
Wagner A; van der Klift H; Franken P; Wijnen J; Breukel C; Bezrookove V; Smits R; Kinarsky Y; Barrows A; Franklin B; Lynch J; Lynch H; Fodde R
Genes Chromosomes Cancer; 2002 Sep; 35(1):49-57. PubMed ID: 12203789
[TBL] [Abstract][Full Text] [Related]
23. No association between MUTYH and MSH6 germline mutations in 64 HNPCC patients.
Steinke V; Rahner N; Morak M; Keller G; Schackert HK; Görgens H; Schmiegel W; Royer-Pokora B; Dietmaier W; Kloor M; Engel C; Propping P; Aretz S;
Eur J Hum Genet; 2008 May; 16(5):587-92. PubMed ID: 18301448
[TBL] [Abstract][Full Text] [Related]
24. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC.
Ollila S; Fitzpatrick R; Sarantaus L; Kariola R; Ambus I; Velsher L; Hsieh E; Andersen MK; Raevaara TE; Gerdes AM; Mangold E; Peltomäki P; Lynch HT; Nyström M
Int J Oncol; 2006 Jan; 28(1):149-53. PubMed ID: 16327991
[TBL] [Abstract][Full Text] [Related]
25. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
26. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
[TBL] [Abstract][Full Text] [Related]
27. The frequency of Muir-Torre syndrome among Lynch syndrome families.
South CD; Hampel H; Comeras I; Westman JA; Frankel WL; de la Chapelle A
J Natl Cancer Inst; 2008 Feb; 100(4):277-81. PubMed ID: 18270343
[TBL] [Abstract][Full Text] [Related]
28. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR].
Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF
Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131
[TBL] [Abstract][Full Text] [Related]
29. Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediated nonhomologous recombination.
Yanaba K; Nakagawa H; Takeda Y; Koyama N; Sugano K
Br J Dermatol; 2008 Jan; 158(1):150-6. PubMed ID: 17941949
[TBL] [Abstract][Full Text] [Related]
30. [Detection of MSH2 gene mutation by PCR].
Zheng D; Liu XP; Li TG; Li J; Tang LJ; Hu WX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):200-3. PubMed ID: 16706114
[TBL] [Abstract][Full Text] [Related]
31. Novel germline and somatic mutations of the MSH2 gene in hereditary non-polyposis colorectal cancer.
Ding DC; Huang RL; Chen CH; Chao CF; Chu TY
Clin Genet; 2007 Feb; 71(2):190-2. PubMed ID: 17250671
[No Abstract] [Full Text] [Related]
32. Solitary subungual keratoacanthoma arising in an MSH2 germline mutation carrier: confirmation of a relationship by immunohistochemical analysis.
Stoebner PE; Fabre C; Delfour C; Joujoux JM; Roger P; Dandurand M; Meunier L
Dermatology; 2009; 219(2):174-8. PubMed ID: 19602866
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.
Flanagan MR; Jayaraj A; Xiong W; Yeh MM; Raskind WH; Pillarisetty VG
World J Gastroenterol; 2015 Mar; 21(9):2820-5. PubMed ID: 25759555
[TBL] [Abstract][Full Text] [Related]
34. Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome.
Sparr JA; Bandipalliam P; Redston MS; Syngal S
Am J Surg Pathol; 2009 Feb; 33(2):309-12. PubMed ID: 18987546
[TBL] [Abstract][Full Text] [Related]
35. A novel MSH2 germline mutation in a Druze HNPCC family.
Zidan J; Niessen RC; Laitman Y; Rozeveld D; Hofstra RM; Friedman E
Fam Cancer; 2008; 7(2):135-9. PubMed ID: 17661183
[TBL] [Abstract][Full Text] [Related]
36. MSH2 splice site mutation and endometrial cancer.
Bianchi F; Rosati S; Belvederesi L; Loretelli C; Catalani R; Mandolesi A; Bracci R; Bearzi I; Porfiri E; Cellerino R
Int J Gynecol Cancer; 2006; 16(3):1419-23. PubMed ID: 16803540
[TBL] [Abstract][Full Text] [Related]
37. The HNPCC associated MSH2*1906G-->C founder mutation probably originated between 1440 CE and 1715 CE in the Ashkenazi Jewish population.
Sun S; Greenwood CM; Thiffault I; Hamel N; Chong G; Foulkes WD
J Med Genet; 2005 Oct; 42(10):766-8. PubMed ID: 16199548
[TBL] [Abstract][Full Text] [Related]
38. A homozygous mutation in MSH6 causes Turcot syndrome.
Hegde MR; Chong B; Blazo ME; Chin LH; Ward PA; Chintagumpala MM; Kim JY; Plon SE; Richards CS
Clin Cancer Res; 2005 Jul; 11(13):4689-93. PubMed ID: 16000562
[TBL] [Abstract][Full Text] [Related]
39. Microsatellite instability is infrequent in medullary breast cancer.
Lee SC; Berg KD; Sherman ME; Griffin CA; Eshleman JR
Am J Clin Pathol; 2001 Jun; 115(6):823-7. PubMed ID: 11392877
[TBL] [Abstract][Full Text] [Related]
40. Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion.
Pastrello C; Baglioni S; Tibiletti MG; Papi L; Fornasarig M; Morabito A; Agostini M; Genuardi M; Viel A
Eur J Hum Genet; 2006 Jan; 14(1):63-8. PubMed ID: 16251890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
